Press Releases

Webcast
Q4 2017 Geron Earnings Conference Call
Mar 19, 2018 at 8:30 AM EDT
Webcast Presentation

Q4 2017 Geron Earnings Conference Call
Mar 19, 2018 at 8:30 AM EDT
Webcast
Geron at 17th Annual Needham Healthcare Conference
Mar 27, 2018 at 4:00 PM EDT
Webcast Presentation

Geron at 17th Annual Needham Healthcare Conference
Mar 27, 2018 at 4:00 PM EDT
Date Title and Summary  
Toggle Summary Geron 2018 Annual Meeting of Stockholders to be Held on May 15
First Quarter 2018 Financial Results to be Announced on May 10 MENLO PARK, Calif. , April 17, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will hold its 2018 Annual Meeting of Stockholders, on Tuesday, May 15, 2018 , at 4:00 p.m. PDT . Geron’s stockholders are invited to attend the
Toggle Summary Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2017 Financial Results
MENLO PARK, Calif. , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2017 , on Friday, March 16, 2018 , after the market close. Geron’s management will also host a conference call for analysts
Toggle Summary Geron Announces Oral Presentation at European Hematology Association Congress
Updated Imetelstat Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes to be Presented MENLO PARK, Calif. , May 17, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that an abstract describing clinical data regarding the telomerase inhibitor imetelstat has been
Toggle Summary Geron Corporation Reports First Quarter 2018 Financial Results
Annual Stockholders Meeting to be Held on May 15, 2018 MENLO PARK, Calif. , May 10, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2018 . First Quarter 2018 Results For the first quarter of 2018, the company reported
Toggle Summary Geron Corporation Reports Fourth Quarter and Annual 2017 Financial Results and Recent Events
Conference Call Scheduled for 8:30 a.m. ET on Monday, March 19 MENLO PARK, Calif. , March 16, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2017 and recent events.
Toggle Summary Geron Reports Imetelstat Oral Presentation at European Hematology Association Congress
Updated Clinical Data from Original Part 1 of IMerge in Myelodysplastic Syndromes (MDS) Presented MENLO PARK, Calif. , June 18, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced the oral presentation of updated data from the ongoing original Part 1 of IMerge, the Phase 2/3
Toggle Summary Geron to Present at the Needham Healthcare Conference
MENLO PARK, Calif. , March 21, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett , M.D., President and Chief Executive Officer, is scheduled to present at the 17th Annual Needham Healthcare Conference in New York at 4:00 p.m.